147 related articles for article (PubMed ID: 32780481)
1. Fatty acid composition of the erythrocyte membrane and risk of hepatocellular carcinoma in cirrhotic patients.
Mouillot T; Rizk M; Pais de Barros JP; Gilloteau A; Busson A; Bernard-Chabert B; Thiefin G; Barraud H; Bronowicki JP; Richou C; Di Martino V; Doffoel M; Minello A; Latournerie M; Jouve JL; Brondel L; Brindisi MC; Petit JM; Hillon P; Cottet V;
Aliment Pharmacol Ther; 2020 Nov; 52(9):1503-1515. PubMed ID: 32780481
[TBL] [Abstract][Full Text] [Related]
2. Arachidonic acid in mononuclear cells and its clinical significance in HCV cirrhotic patients.
Okita M; Tomioka K; Ota Y; Sasagawa T; Osawa T; Sakai N; Kawaguchi M; Itoshima T
Nutrition; 2003 Sep; 19(9):727-32. PubMed ID: 12921881
[TBL] [Abstract][Full Text] [Related]
3. Circulating Fatty Acids Associated with Advanced Liver Fibrosis and Hepatocellular Carcinoma in South Texas Hispanics.
Jiao J; Kwan SY; Sabotta CM; Tanaka H; Veillon L; Warmoes MO; Lorenzi PL; Wang Y; Wei P; Hawk ET; Almeda JL; McCormick JB; Fisher-Hoch SP; Beretta L
Cancer Epidemiol Biomarkers Prev; 2021 Sep; 30(9):1643-1651. PubMed ID: 34155064
[TBL] [Abstract][Full Text] [Related]
4. [Fatty acid composition of phospholipids of erythrocyte membranes and risk of breast cancer].
Zaridze DG; Shevchenko VE; Levchuk AA; Lifanova EE
Vopr Onkol; 1990; 36(12):1442-8. PubMed ID: 2126901
[TBL] [Abstract][Full Text] [Related]
5. Serum Phospholipid Fatty Acid Composition in Cystic Fibrosis Patients with and without Liver Cirrhosis.
Drzymała-Czyż S; Szczepanik M; Krzyżanowska P; Duś-Żuchowska M; Pogorzelski A; Sapiejka E; Juszczak P; Lisowska A; Koletzko B; Walkowiak J
Ann Nutr Metab; 2017; 71(1-2):91-98. PubMed ID: 28738321
[TBL] [Abstract][Full Text] [Related]
6. Erythrocyte membrane phospholipid fatty acids, desaturase activity, and dietary fatty acids in relation to risk of type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study.
Kröger J; Zietemann V; Enzenbach C; Weikert C; Jansen EH; Döring F; Joost HG; Boeing H; Schulze MB
Am J Clin Nutr; 2011 Jan; 93(1):127-42. PubMed ID: 20980488
[TBL] [Abstract][Full Text] [Related]
7. Fatty acid composition of phospholipids in erythrocyte membranes and risk of breast cancer.
Zaridze DG; Chevchenko VE; Levtshuk AA; Lifanova YE; Maximovitch DM
Int J Cancer; 1990 May; 45(5):807-10. PubMed ID: 2335383
[TBL] [Abstract][Full Text] [Related]
8. Abnormalities in Plasma Phospholipid Fatty Acid Profiles of Patients with Hepatocellular Carcinoma.
Qiu JF; Zhang KL; Zhang XJ; Hu YJ; Li P; Shang CZ; Wan JB
Lipids; 2015 Oct; 50(10):977-85. PubMed ID: 26294003
[TBL] [Abstract][Full Text] [Related]
9. Fatty acids of erythrocyte membrane in acute pancreatitis patients.
Kuliaviene I; Gulbinas A; Cremers J; Pundzius J; Kupcinskas L; Dambrauskas Z; Jansen E
World J Gastroenterol; 2013 Sep; 19(34):5678-84. PubMed ID: 24039361
[TBL] [Abstract][Full Text] [Related]
10. Variation in human erythrocyte membrane unsaturated Fatty acids: correlation with cardiovascular disease.
Sepulveda JL; Tanhehco YC; Frey M; Guo L; Cropcho LJ; Gibson KM; Blair HC
Arch Pathol Lab Med; 2010 Jan; 134(1):73-80. PubMed ID: 20073608
[TBL] [Abstract][Full Text] [Related]
11. Assessment of erythrocyte phospholipid fatty acid composition as a biomarker for dietary MUFA, PUFA or saturated fatty acid intake in a controlled cross-over intervention trial.
Poppitt SD; Kilmartin P; Butler P; Keogh GF
Lipids Health Dis; 2005 Dec; 4():30. PubMed ID: 16329761
[TBL] [Abstract][Full Text] [Related]
12. Abnormal octadeca-carbon fatty acids distribution in erythrocyte membrane phospholipids of patients with gastrointestinal tumor.
Lin S; Li T; Liu X; Wei S; Liu Z; Hu S; Liu Y; Tan H
Medicine (Baltimore); 2017 Jun; 96(24):e7189. PubMed ID: 28614260
[TBL] [Abstract][Full Text] [Related]
13. Dietary components modulate the risk of hepatocellular carcinoma in cirrhotic patients.
Rizk M; Guilloteau A; Mouillot T; Thiefin G; Bronowicki JP; Richou C; Doffoel M; Diab Assaf M; Hillon P; Cottet V
Nutr Res; 2019 Jan; 61():82-94. PubMed ID: 30683441
[TBL] [Abstract][Full Text] [Related]
14. Role of circulating miR-182 and miR-150 as biomarkers for cirrhosis and hepatocellular carcinoma post HCV infection in Egyptian patients.
Shaheen NMH; Zayed N; Riad NM; Tamim HH; Shahin RMH; Labib DA; ELsheikh SM; Moneim RA; Yosry A; Khalifa RH
Virus Res; 2018 Aug; 255():77-84. PubMed ID: 30003924
[TBL] [Abstract][Full Text] [Related]
15. Potential role of diabetes mellitus in the progression of cirrhosis to hepatocellular carcinoma: a cross-sectional case-control study from Chinese patients with HBV infection.
Gao C; Fang L; Zhao HC; Li JT; Yao SK
Hepatobiliary Pancreat Dis Int; 2013 Aug; 12(4):385-93. PubMed ID: 23924496
[TBL] [Abstract][Full Text] [Related]
16. Association between Erythrocyte Membrane Phospholipid Fatty Acids and Sleep Disturbance in Chinese Children and Adolescents.
Tang J; Yan Y; Zheng JS; Mi J; Li D
Nutrients; 2018 Mar; 10(3):. PubMed ID: 29534525
[TBL] [Abstract][Full Text] [Related]
17. Dietary fatty acids and risk of hepatocellular carcinoma in the Singapore Chinese health study.
Koh WP; Dan YY; Goh GB; Jin A; Wang R; Yuan JM
Liver Int; 2016 Jun; 36(6):893-901. PubMed ID: 26443688
[TBL] [Abstract][Full Text] [Related]
18. Fatty acids measured in plasma and erythrocyte-membrane phospholipids and derived by food-frequency questionnaire and the risk of new-onset type 2 diabetes: a pilot study in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Norfolk cohort.
Patel PS; Sharp SJ; Jansen E; Luben RN; Khaw KT; Wareham NJ; Forouhi NG
Am J Clin Nutr; 2010 Nov; 92(5):1214-22. PubMed ID: 20861175
[TBL] [Abstract][Full Text] [Related]
19. Serum and erythrocyte membrane phospholipids fatty acid composition in hyperlipidemia: effects of dietary intervention and combined diet and fibrate therapy.
Ristic-Medic D; Suzic S; Vucic V; Takic M; Tepsic J; Glibetic M
Gen Physiol Biophys; 2009; 28 Spec No():190-9. PubMed ID: 19893100
[TBL] [Abstract][Full Text] [Related]
20. Abnormality in membrane fatty acid compositions of cells measured on erythrocyte in alcoholic liver disease.
Shiraishi K; Matsuzaki S; Itakura M; Ishida H
Alcohol Clin Exp Res; 1996 Feb; 20(1 Suppl):56A-59A. PubMed ID: 8659691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
